Tag: AstraZeneca PLC

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

AstraZeneca’s trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?

AstraZeneca stock dives 9% after heart drug trial misses target

Drugmakers race to find a place in the next wave of obesity drugs

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed

FDA chief Marty Makary says ‘everything should be over-the-counter’ unless drug is unsafe or addictive

World leaders flock to Beijing, hedging against U.S. disruptions